Upload
vanthien
View
232
Download
0
Embed Size (px)
Citation preview
V.19
REGISTER ONLINE cumming.ucalgary.ca/cme
PAPERLESS CONFERENCE Access to handouts will be available prior to conference
ON-SITE REGISTRATION Based on availability, is not guaranteed and a surcharge may be applied
Check the website for any program updates cumming.ucalgary.ca/cme/courses
ACCOMMODATION
Registrants must make their own accommodation arrangements. Hotel(s) close to the University/course venue include:
Hotel Alma169 University Gate NW Calgary, AB T2N 1N4Phone 403.220.2588Toll Free 1.877.498.3203Email [email protected]
To obtain a University rate, please indicate the promotion code UOFC and show your CME&PD course confirmation/receipt upon arrival.
COURSE OVERVIEW
This course provides evidence-based information about the pharmacology, methods of ingestion, adverse effects across the lifespan, medical uses of cannabis and effects on driving. Participants will learn about the diagnosis and treatment of medical emergencies involving cannabis and how to screen patients for cannabis use and for cannabis use disorder. Also covered are how to determine whether patients have contraindications for cannabis use, and the process for authorizing cannabis for medical purposes in appropriate patients.
COURSE OBJECTIVES
At the end of this course, learners will be equipped to:• summarize basic information about the pharmacology, methods of ingestion and adverse
effects of cannabis and its analogues• discuss the evidence supporting the use of cannabis for medical purposes• describe the types of cannabis related medical emergencies and their treatment• discuss the effects of cannabis on driving• discuss the effects of cannabis throughout the life span• counsel patients on cannabis use• screen patients for cannabis use disorder and identify appropriate treatment• discuss Alberta Health Services policies around cannabis use in hospital and homecare settings
WHO SHOULD ATTEND
Physicians, Pharmacists, Nurse Practitioners, Registered Nurses, Psychologists, Social Workers, Other Health Professionals, Residents and Trainees
CREDITS
Mainpro+ Group Learning – 6.75 credits | MOC Section 1 – 6.75 hours
The Canadian Council on Continuing Education in Pharmacy has accredited this program for 6.91 CEUs. Pharmacists Program Number: 1180-2018-2635-C-P, Accreditation Date: 2019-04-24, Accreditation Expiry Date: 2019-04-25. Pharmacy Technicians Program Number: 1180-2018-2636-C-T, Accreditation Date: 2019-04-24, Accreditation Expiry Date: 2019-04-25.
Practical Skills for Working with Patients Around CannabisCALGARY THERAPEUTICS PRE-COURSE
CANNABIS UPDATE 2019
Wednesday, April 24, 2019Red & White Club, 1833 Crowchild Trail NW, Calgary, AB
cumming.ucalgary.ca/cme
CANNABIS UPDATE 2019 | PAGE 1 OF 9
CUMMING SCHOOL OF MEDICINE Office of Continuing Medical Education and Professional Development
V.19
Wednesday, April 24
0630-0800 Registration / Light Breakfast
0700-0745 PRE-COURSE PLENARY Cannabis 101 – Lori Montgomery
• describe cannabis pharmacology in terms patients can understand
• outline the major adverse effects of cannabis
• explain to a patient how different routes of dosing affect their response to cannabis
This session is intended for those with limited baseline knowledge of cannabis. Content in this presentation was covered at previous Cannabis Updates in 2017 and 2018.
0745-0800 Break
0800-0815 Opening Remarks – Barry Baylis, Lori Montgomery
0815-0900 PLENARY Cannabis in the Emergency Department – Eddy Lang
• discuss the Alberta data regarding cannabis related presentations to emergency departments
• describe the characteristics of cannabis related emergencies (psychosis, prolonged QT, hyperemesis) and basic treatment approaches
• discuss the “lessons learned” from cannabis related ED presentations in other jurisdictions
• counsel patients about the adverse effects of cannabis
0900-0945 PLENARY The Highs and Lows of Medical Cannabis – Tina Korownyk
• list known uses for cannabis for medical purposes for which there is evidence
• discuss any updates in the literature on evidence-based medical uses for cannabis
• refer to published guidelines on cannabis for medical use to provide guidance for patient use
• counsel patients on whether cannabis is an appropriate treatment for their medical needs
0945-1000 Nutrition Break
1000-1045 PLENARY
PART 1 – A Synthesis of Cannabis and Driving Research
– Jeff Caird
• synthesize research on crash risk and driving performance in drivers who have consumed cannabis
• provide practical guidance on medical and recreational cannabis use and driving
PART 2 – Update on Driving and Cannabis Use – Len Stefaniuk
• describe the roadside process for screening for impairment
• summarize the local experience with enforcement since the legalization of cannabis
• discuss the impact of recent changes in alcohol screening processes on screening drivers for cannabis use
1045-1105 SHORT SNAPPER Synthetic Cannabinoid Analogues –
New Designer Drugs – Barry Baylis
• list the most common illicit synthetic cannabinoid analogues
• describe the pharmacology of synthetics in comparison with endogenous and exogenous cannabinoids
• describe the presentations in the emergency department of patients who use these analogues
• discuss the treatment of patients who suffer from acute adverse effects of these analogues
1 105-1110 RESEARCH UPDATE Survey of the Perceived Benefits and Adverse
Effects of Cannabis Usage in Canadian Youth – Christine Ashenhurst, Vivian Hill, John Huang,
Emi Sanders
• recognize the perceptions of Canadian adolescents pre-legalization in a unique survey
• review possible areas for further study
COURSE PROGRAM
PROGRAM MAY CHANGE DUE TO CIRCUMSTANCES BEYOND OUR CONTROL
cumming.ucalgary.ca/cme
CANNABIS UPDATE 2019 | PAGE 2 OF 9
V.19
COURSE PROGRAM
PROGRAM MAY CHANGE DUE TO CIRCUMSTANCES BEYOND OUR CONTROL
cumming.ucalgary.ca/cme
CANNABIS UPDATE 2019 | PAGE 3 OF 9
1110-1210 KEYNOTE Cannabinoids and Development of the Brain – Diana Dow Edwards
• summarize the effects of legalization on the epidemiology of cannabis use
• describe the prenatal effects of maternal cannabis use on child development
• describe the effects of adolescent cannabis use on cognition, mental health and substance abuse
1210-1305 Lunch
1305-1335 SHORT SNAPPER Assessing a Patient for Medical Cannabis –
To Authorize or Not to Authorize – Lydia Hatcher
• describe how to make informed decisions about whether a patient is a candidate for the use of medical cannabis
• use of validated tools to help screen for cautions and contraindications
1335-1345 Move to Workshops 1-3
1345-1445 CONCURRENT WORKSHOPS 1-3
1 How to Authorize Cannabis for Your Patient – Lydia Hatcher
• counsel a patient on how to choose a licensed producer
• complete the form to authorize cannabis following the College of Physicians and Surgeons of Alberta standard of practice
• counsel a patient regarding type of cannabis product (percentage THC, CBD or both), amount and method of ingestion
2 Screening for Cannabis Use Disorder and the Next Steps
– Monty Ghosh• choose an appropriate screening tool to
screen patients for cannabis use disorder
• screen and diagnose patients for cannabis use disorder
• describe appropriate treatment options for patients with cannabis use disorder
3 Balancing Patient-centred Care and Healthcare Provider Safety
– Michelle Kilborn• summarize the AHS patient cannabis use
policies in AHS facilities and in the community (homecare) settings
• outline the level of risk faced by providers whose patients use cannabis in their presence
• discuss the balance of patient-centred care and healthcare provider safety
1445-1455 Nutrition Break / Move to Workshops 4-6
1455-1555 CONCURRENT WORKSHOPS 4-6
4 Cannabis and the Cardiovascular System – Michael Slawnych
• indicate the risks of cannabis use for patients with cardiovascular disease
• describe the level of evidence for benefit in patients with cardiovascular disease
• discuss case studies of patients with cardiovascular disease who are using or want to use cannabis and counsel them about cannabis use
5 Assessing Older Adults for Cannabis Use – Lori Montgomery, Jim Silvius
• describe the implications of cannabis use with increasing age
• develop an approach to counselling the older patient and their families regarding cannabis use
• discuss case studies involving older adults and whether cannabis use is appropriate
6 Use of Cannabis in Palliative Care – Rizwan Qureshi
• indicate when cannabis is of use for symptom control in patients in palliative care (e.g. appetite, pain relief)
• discuss the risk assessment of patients in a palliative context and the use of cannabis
1555 Adjournment
V.19
PLANNING COMMITTEE
Barry Baylis MD FRCPC Course Co-Chair Clinical Associate Professor, Department of Medicine, Cumming School of Medicine, University of Calgary
Lori Montgomery MD CCFP Course Co-Chair Clinical Associate Professor, Department of Family Medicine and Department of Anesthesiology, Perioperative and Pain Medicine, University of Calgary; Medical Leader, Chronic Pain Centre, Alberta Health Services, Calgary Zone
Elwyn Brown MD CCFP Family Physician, Calgary
Michelle Gibbens BSW MSW Manager, Implementation Support – Western Canada, CADTH
Ruth-Ann Gingrich BScPharm MSc CSPI Community Pharmacist, Shoppers Drug Mart, Calgary; Pharmacist, PADIS
Jerry Hanen BScPharm Pharmacist, Alberta Health Services
John Huang MD FRCSC Clinical Associate Professor, Department of Surgery, Cumming School of Medicine, University of Calgary
Maria James BSP Clinical Pharmacist, Calgary Co-op, Calgary
Marsha Kucera MD CCFP Clinical Lecturer, Cumming School of Medicine, University of Calgary; Family Physician, Sunridge Medical Clinic, Calgary
Kathy Lee BScPharm Pharm D Pharmacist, PADIS
Lisa Lix BScPharm Community Pharmacist, Black Diamond
Ashi Mehta BSc MSc MD Project Manager, Physician Learning Program, University of Calgary
Sheldon Roth PhD BSc MSc Professor Emeritus, Cumming School of Medicine, University of Calgary
Cheryl Sadowski BSc (Pharm) PharmD BCGP FCSHP Professor, Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta
Rhonda Shkrobot BScPharm ACPR Interim Alberta Liaison Officer, Implementation Support & Knowledge Mobilization; CADTH
Karen Then RN CCN(C) ACNP PhD Professor, Faculty of Nursing, University of Calgary
Diane Simpson PhD MDE CME Representative Education Consultant, Office of Continuing Medical Education and Professional Development, University of Calgary
cumming.ucalgary.ca/cme
CANNABIS UPDATE 2019 | PAGE 4 OF 9
V.19
FACULTY
Barry Baylis MD FRCPC Course Co-Chair Clinical Associate Professor, Department of Medicine, Cumming School of Medicine, University of Calgary
Lori Montgomery MD CCFP Course Co-Chair Clinical Associate Professor, Department of Family Medicine and Department of Anesthesiology, Perioperative and Pain Medicine, University of Calgary; Medical Leader, Chronic Pain Centre, Alberta Health Services, Calgary Zone
Christine Ashenhurst Grade 11 Student, West Island College, Calgary
Jeff Caird PhD Professor, Departments of Psychology and Community Health Sciences, University of Calgary
Diana Dow Edwards PhD Professor of Physiology & Pharmacology, State University of New York
Monty Ghosh BSc MBT MSc MD FRCPC DM-EMDM ISAM(C) Internal Medicine and Addiction Medicine, Department of General Internal Medicine, University of Alberta; Internal Medicine Specialist, The Alex, Calgary
Lydia Hatcher MD CCFP FCFP CHE D-CAPM Associate Clinical Professor, Department of Family Medicine, McMaster University
Vivian Hill MD FRCPC Clinical Assistant Professor, Department of Surgery, University of Calgary; Pediatric Ophthalmologist, Private Practice, Calgary
John Huang MD FRCPC Clinical Associate Professor, Department of Surgery, Cumming School of Medicine, University of Calgary
Michelle Kilborn PhD AHS Cannabis Project Coordinator, Population, Public and Indigenous Health, Alberta Health Services
Tina Korownyk MD CCFP Associate Professor, Department of Family Medicine, Faculty of Medicine & Dentistry, University of Alberta; Assistant Director, Evidence and CPD, Alberta College of Family Physicians
Eddy Lang MDCM CCFP (EM) CSPQ Professor, Emergency Medicine, University of Calgary; Clinical and Academic Department Head for Emergency Medicine, Cumming School of Medicine, Alberta Health Services, Calgary Zone
Rizwan Qureshi MD Clinical Associate, Tom Baker Cancer Centre, Alberta Health Services
Emi Sanders BSc AHS Researcher / Clinical Admin
Jim Silvius FRCPC SPEC COMP Clinical Associate Professor, Department of Medicine, University of Calgary; Provincial Medical Director, Community Seniors Addiction & Mental Health; Senior Medical Director, Seniors Health Strategic Clinical Network
Michael Slawnych MD FRCPC Clinical Assistant Professor, Cardiac Sciences, Department of Medicine, Cumming School of Medicine, University of Calgary
Len Stefaniuk CPS Alcohol and Drug Recognition Unit (ADRU), Calgary Police Service, Traffic Section
DISCLOSURE OF POTENTIAL FINANCIAL CONFLICTS OF INTEREST
In keeping with accreditation guidelines, speakers participating in this event have been asked to disclose to the audience any involvement with industry or other organizations that may potentially influence the presentation of the educational material. Disclosure will be done verbally and using a slide prior to the speaker’s presentation.
cumming.ucalgary.ca/cme
CANNABIS UPDATE 2019 | PAGE 5 OF 9
V.19
ACCREDITATION
STUDY CREDITS
The University of Calgary – Office of Continuing Medical Education and Professional Development is fully accredited by the Committee on Accreditation of Continuing Medical Education (CACME).
CFPC
MAINPRO+ GROUP LEARNING
This one-credit-per-hour Group Learning program meets the certification criteria of The College of Family Physicians of Canada and has been certified by the University of Calgary Office of Continuing Medical Education and Professional Development for up to 6.75 Mainpro+ credits.
AACP
AMERICAN ACADEMY OF FAMILY PHYSICIANS (AAFP) AND CFPC
Members of the American Academy of Family Physicians are eligible to receive up to 6.75 prescribed credits for attendance at this meeting/event due to a reciprocal agreement with The College of Family Physicians of Canada.
RCPSC
MOC SECTION 1
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by University of Calgary Office of Continuing Medical Education and Professional Development. You may claim a maximum of 6.75 hours (credits are automatically calculated).
AMA-PRA CATEGORY 1 CREDIT
Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™. More information on the process to convert Royal College MOC credit to AMA credit at https://www.ama-assn.org/education/earn-credit-participation-international-activities.
Read more on the Royal College agreement with the American Medical Association at http://www.royalcollege.ca/rcsite/cpd/providers/international-accreditation-agreements-e.
PHARMACISTS
CANADIAN COUNCIL ON CONTINUING EDUCATION IN PHARMACY
The Canadian Council on Continuing Education in Pharmacy has accredited this program for 6.91 CEUs. Pharmacists Program Number: 1180-2018-2635-C-P, Accreditation Date: 2019-04-24, Accreditation Expiry Date: 2019-04-25. Pharmacy Technicians Program Number: 1180-2018-2636-C-T, Accreditation Date: 2019-04-24, Accreditation Expiry Date: 2019-04-25.
cumming.ucalgary.ca/cme
CANNABIS UPDATE 2019 | PAGE 6 OF 9
V.19
ADDITIONAL PROGRAM INFORMATION
DRESS
Dress is business casual. Sweaters or items of clothing that can be layered are recommended since temperature in the venue may fluctuate.
MEALS
In general, each course offers a light breakfast, nutrition break(s) and lunch. We are sensitive to dietary requirements (for example, gluten free, peanut allergies) and do our best to offer a variety of options; however we are unable to guarantee that all dietary needs can be accommodated.
SCENT FREE
To ensure the comfort of everyone attending this event, please do not wear scented products.
CONFIRMATION OF REGISTRATION
Confirmation will be sent by email to registrants.
COURSE CANCELLATION POLICY
The Office of Continuing Medical Education and Professional Development reserves the right to cancel the course if there are insufficient registrations.
REFUND POLICY
A registration refund will be made upon written request if made at least two weeks before the start of the program; however $50 will be retained for administrative costs. No refunds will be available for cancellations made within two weeks of the start of the program and thereafter.
REIMBURSEMENT OF REGISTRATION FEES
Physicians may be eligible for reimbursement of registration fees and expenses to attend CME courses from a fund administered by the Alberta Medical Association. For more information regarding this, please call the AMA at 780.482.2626 or 1.800.272.9680.
FOR FURTHER INFORMATION
Office of Continuing Medical Education and Professional Development, Cumming School of Medicine, University of Calgary, TRW Building, 3280 Hospital Drive NW, Calgary, AB T2N 4Z6
ABOUT COURSE CONTENT
Diane Simpson, Education Consultant Phone 403.210.8804 Email [email protected]
Dana Young, Education Coordinator Phone 403.210.6226 Email [email protected]
ABOUT GENERAL PROGRAM INFORMATION
Monica Rast, Program Assistant Phone 403.220.6493 Email [email protected]
ABOUT REGISTRATION
Phone 403.220.7032 Email [email protected]
cumming.ucalgary.ca/cme
CANNABIS UPDATE 2019 | PAGE 7 OF 9
V.19
REGISTRATION FEEPLUS 5% GST – UCalgary GST Registration #108102864RT0001ADD 5% TO FEE(S) BELOW TO CALCULATE TOTAL COURSE FEE
EARLY RATE on or before March 19, 2019
$ 295.00 Physician
$ 295.00 Other Health Professional
$ 150.00 Student / Resident (FULL-TIME STUDENTS ONLY)
REGULAR RATE after March 19, 2019
$ 350.00 Physician
$ 350.00 Other Health Professional
$ 150.00 Student / Resident (FULL-TIME STUDENTS ONLY)
ON-SITE RATE (Based on availability and not guaranteed)
$ 420.00 Physician
$ 420.00 Other Health Professional
$ 150.00 Student / Resident (FULL-TIME STUDENTS ONLY)
Cannabis Update 2019 April 24, 2019
COURSE # – 10021692-30006
FIRST NAME
EXPIRY DATE
LAST NAME
ADDRESS
CITY
AREA CODE PHONE AREA CODE FAX
CHEQ M YM Y
SIGNATURE
AMEX VISA MASTERCARD
CARD NUMBER
PROVINCE POSTAL CODE
EXT
REGISTER
ONLINEcumming.ucalgary.ca/cme
BY CONFIDENTIAL FAXFax 403.270.2330
For your protection, the University of Calgary does not accept and will not process credit card information provided via email or text messages
BY MAILCheque Payable – UNIVERSITY OF CALGARY
CHEQUE MUST INCLUDE 5% GST
Cumming School of Medicine, Office of Continuing Medical Education and Professional Development, University of Calgary, TRW Building, 3280 Hospital Drive NW, Calgary, AB T2N 4Z6
REGISTRATION SERVICESPhone 403.220.7032 Email [email protected]
REGISTRATION FORM
cumming.ucalgary.ca/cme
FREEDOM OF INFORMATION AND PROTECTION OF PRIVACY ACT Registration information is collected under the authority of the Freedom of Information and Protection of Privacy Act. The contact information you provide is required by our Office to register you in the course, prepare material and courses for your use, plan for future courses and notify you of similar, upcoming courses offered by our Office. Financial information is used to process applicable fees and is retained for future reference. Call 403.220.4251 if you have questions about the collection or use of this information.
CANNABIS UPDATE 2019 | PAGE 8 OF 9
PAYMENT BY COMPLETE REGISTRATION FORM Part 2 >>
Part 1PROFESSION
COMMUNITY SIZE IN WHICH YOU PRACTICE
YEARS OF PRACTICE – PLEASE SPECIFY
GREATER THAN 1,000,000 INHABITANTS
15,001-999,999 INHABITANTS
0-15,000 INHABITANTS
FAMILY PHYSICIAN NURSE PRACTITIONER
SPECIALIST PHYSICIAN – PLEASE SPECIFY OTHER HEALTH PROFESSIONAL – PLEASE SPECIFY
PHARMACIST STUDENT/RESIDENT (FULL-TIME STUDENTS ONLY)
UCID(IF APPLICABLE)
DATE OF BIRTHM DM D
V.19
Cannabis Update 2019 April 24, 2019
REGISTRATION FORM
FIRST NAME
LAST NAME
Part 2
CONCURRENT WORKSHOPS SELECTIONS
cumming.ucalgary.ca/cme
Workshops 1-3 • 1345-1445 Select 3 – Number in order of preference with 1 being most important
1 How to Authorize Cannabis for Your Patient
2 Screening for Cannabis Use Disorder and the Next Steps
3 Balancing Patient-centred Care and Healthcare Provider Safety
Workshops 4-6 • 1455-1555 Select 3 – Number in order of preference with 1 being most important
4 Cannabis and the Cardiovascular System
5 Assessing Older Adults for Cannabis Use
6 Use of Cannabis in Palliative Care
CANNABIS UPDATE 2019 | PAGE 9 OF 9